首页 | 本学科首页   官方微博 | 高级检索  
检索        

武汉地区33家医院2008-2010年双膦酸盐药物应用分析
引用本文:张程亮,吕操,刘东.武汉地区33家医院2008-2010年双膦酸盐药物应用分析[J].中国药物应用与监测,2011,8(6):372-374,378.
作者姓名:张程亮  吕操  刘东
作者单位:华中科技大学同济医学院附属同济医院药学部,湖北武汉,430030
摘    要:目的:研究双膦酸盐在武汉地区33家医院2008–2010年的应用情况和发展趋势。方法:采用世界卫生组织推荐的限定日剂量为指标的分析方法,对武汉地区33家医院2008–2010年双膦酸盐有关数据进行统计分析。结果:双膦酸盐销售金额和用药频度逐年增加。第一代双膦酸盐氯屈膦酸的使用呈现下降趋势,第二代和第三代双膦酸盐占据了主要市场,其中以唑来膦酸和阿仑膦酸为主。结论:双膦酸盐在骨吸收相关性疾病中的应用逐渐受到重视,第一代双膦酸盐仍有一定的应用,但第二代和第三代双膦酸盐已经占据了主要市场。

关 键 词:双膦酸盐  限定日剂量  用药频度

Analysis of consumption of diphosphonate in 33 hospitals of Wuhan area during the period of 2008 - 2010
Authors:ZHANG Cheng-liang  LV Cao  LIU Dong
Institution:ZHANG Cheng-liang,LV Cao,LIU Dong(Department of Pharmacy,Tongji Hospital Affiliated to Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)
Abstract:Objective: To evaluate the status quo and the developmental tendency of consumption of diphosphonate in 33 hospitals of Wuhan during the period of 2008 – 2010.Methods: Using the analytical method of the defined daily dose(DDD) recommended by the WHO,the data of diphosphonate in 33 hospitals of Wuhan from 2008 – 2010 were statistically analyzed in respect to consumption sum and DDDs.Results: During the past three years,the consumption sums and DDDs of diphosphonate increased yearly.The application of clodronate,the 1st generation diphosphonate,decreased in Wuhan.The 2nd and 3rd generation diphosphonates were widely used and took a high proportion of the market,especially for zoledronic acid and alendronic acid.Conclusion: The use of diphosphonates was paid more attention to in bone resorption diseases.The 1st generation diphosphonates were still used in clinical practice,while the 2nd and 3rd generation diphosphonates were the most widely used diphosphonates which occupied the major market.
Keywords:Diphosphonate  Defi ned daily dose  DDDs  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号